Causal Associations of DNA Methylation and Cardiovascular Disease: A Two-Sample Mendelian Randomization Study
Global Heart · 14.05.2024 · 19 (1) · 48
DOI: 10.5334/gh.1324 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global Heart, online erschienen am 14.05.2024. Verfasst von Hui Gao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, The First People's Hospital of Shangqiu, Shangqiu 476000, China. Hauptthemen laut MEDLINE: DNA Methylation, Mendelian Randomization Analysis, Cardiovascular Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Henan Province medical science and technology research.
Abstract (Originalsprache)
Background
There is growing evidence that concentrations of DNA methylation are associated with cardiovascular disease; however, it is unclear whether this association reflects a causal relationship.
Methods
We utilized a two-sample Mendelian randomization (MR) approach to investigate whether DNA methylation can affect the risk of developing cardiovascular disease in human life. We primarily performed the inverse variance weighted (IVW) method to analyze the causal effect of DNA methylation on multiple cardiovascular diseases. Additionally, to ensure the robustness of our findings, we conducted several sensitivity analyses using alternative methodologies. These analysis methods included maximum likelihood, MR-Egger regression, weighted median method, and weighted model methods.
Results
Inverse variance weighted estimates suggested that an SD increase in DNA methylation Hannum age acceleration exposure increased the risk of cardiac arrhythmias (OR = 1.03, 95% CI 1.00–1.05, p = 0.0290) and atrial fibrillation (OR = 1.03, 95% CI 1.00–1.05, p = 0.0022). We also found that an SD increase in DNA methylation PhenoAge acceleration exposure increased the risk of heart failure (OR = 1.01, 95% CI 1.00–1.03, p = 0.0362). Exposure to DNA methylation-estimated granulocyte proportions was found to increase the risk of hypertension (OR = 1.00, 95% CI 1.00–1.0001, p = 0.0291). Exposure to DNA methylation-estimated plasminogen activator inhibitor-1 levels was found to increase the risk of heart failure (OR = 1.00, 95% CI 1.00–1.00, p = 0.0215).
Conclusion
This study reveals a causal relationship between DNA methylation and CVD. Exposed to high levels of DNA methylation Hannum age acceleration inhabitants with an increased risk of cardiac arrhythmias and atrial fibrillation. DNA methylation PhenoAge acceleration levels exposure levels were positively associated with the increased risk of developing heart failure. This has important implications for the prevention of cardiovascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, The First People's Hospital of Shangqiu, Shangqiu 476000, China.
- Graduate School, Dalian Medical University, Dalian, 116044, China.
- Department of Cardiovascular Medicine, The First People's Hospital of Qinzhou, Qinzhou 535000, China.
- Department of Cardiovascular Medicine, Central Hospital of Zibo, Zibo 255000, China.
- Department of Hypertension, Henan Provincial People's Hospital, Zhengzhou 450000, China.
ORCID-Profile: Hui Gao, Jiahai Li, Qiaoli Ma, Qinghui Zhang, Man Li, Xiaoliang Hu
Förderung
- Henan Province medical science and technology research
Zitieren
APA
Gao, H., Li, J., Ma, Q., Zhang, Q., Li, M., & Hu, X. (2024). Causal Associations of DNA Methylation and Cardiovascular Disease: A Two-Sample Mendelian Randomization Study. Global Heart, 19(1), 48. https://doi.org/10.5334/gh.1324
Vancouver
Gao H, Li J, Ma Q, Zhang Q, Li M, Hu X. Causal Associations of DNA Methylation and Cardiovascular Disease: A Two-Sample Mendelian Randomization Study. Global Heart. 2024;19(1):48. doi:10.5334/gh.1324
BibTeX
@article{Gao2024,
author = {Gao, Hui and Li, Jiahai and Ma, Qiaoli and Zhang, Qinghui and Li, Man and Hu, Xiaoliang},
title = {Causal Associations of DNA Methylation and Cardiovascular Disease: A Two-Sample Mendelian Randomization Study},
journal = {Global Heart},
year = {2024},
volume = {19},
number = {1},
pages = {48},
doi = {10.5334/gh.1324}
}
EUVIMED